Previous studies reported that CRKL enhances malignancy of the cancers such as glioblastoma (Lv et al., 2013), breast cancer (Zhao et al., 2013), and colon cancer (Lan et al., 2014). The gene discussed is CRKL; the disease is breast cancer.